Companies

Adaptimmune

Description: Adaptimmune is a cellular therapeutics company developing affinity enhanced T-cell receptor (TCR) engineered T-cells to treat solid tumor and hematological cancers.

Location: Oxford, UK

Sector: Healthcare

Year Invested: 2014

Status: Public (NASDAQ: ADAP)

Website: www.adaptimmune.com

Back to Companies

Associated Team Members